HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tissue-engineered Vascular Grafts in Children With Congenital Heart Disease: Intermediate Term Follow-up.

Abstract
Tissue engineering holds great promise for the advancement of cardiovascular surgery as well as other medical fields. Tissue-engineered vascular grafts have the ability to grow and remodel and could therefore make great advances for pediatric cardiovascular surgery. In 2001, we began a human clinical trial evaluating these grafts in patients with a univentricular physiology. Herein, we report the long-term results of patients who underwent implantation of tissue-engineered vascular grafts as extracardiac total cavopulmonary conduits. Tissue-engineered vascular grafts seeded with autologous bone marrow mononuclear cells were implanted in 25 patients with univentricular physiology. The graft is composed of a woven fabric of poly-l-lactide acid or polyglycolic acid and a 50:50 poly (l-lactic-co-ε-caprolactone) copolymer. Patients were followed up with postoperatively in a multidisciplinary clinic. Median patient age at operation was 5.5 years and the mean follow-up period was 11.1 years. There was no graft-related mortality during the follow-up period. There was also no evidence of aneurysmal formation, graft rupture, graft infection, or calcification. Seven (28%) patients had asymptomatic graft stenosis and underwent successful balloon angioplasty. Stenosis is the primary complication of the tissue-engineered vascular graft. Avoidance of anticoagulation therapy would improve patients' quality of life. Tissue-engineered vascular grafts have feasibility in pediatric cardiovascular surgery.
AuthorsTadahisa Sugiura, Goki Matsumura, Shinka Miyamoto, Hideki Miyachi, Christopher K Breuer, Toshiharu Shinoka
JournalSeminars in thoracic and cardiovascular surgery (Semin Thorac Cardiovasc Surg) Vol. 30 Issue 2 Pg. 175-179 ( 2018) ISSN: 1532-9488 [Electronic] United States
PMID29427773 (Publication Type: Clinical Trial, Journal Article, Video-Audio Media)
CopyrightCopyright © 2018 Elsevier Inc. All rights reserved.
Chemical References
  • Polyesters
  • poly(lactic acid-co-epsilon-caprolactone)
Topics
  • Adolescent
  • Age Factors
  • Angioplasty, Balloon
  • Bioprosthesis
  • Blood Vessel Prosthesis
  • Blood Vessel Prosthesis Implantation (adverse effects, instrumentation)
  • Child
  • Child, Preschool
  • Computed Tomography Angiography
  • Feasibility Studies
  • Female
  • Follow-Up Studies
  • Fontan Procedure (adverse effects, instrumentation)
  • Graft Occlusion, Vascular (diagnostic imaging, physiopathology, therapy)
  • Heart Defects, Congenital (diagnostic imaging, physiopathology, surgery)
  • Humans
  • Infant
  • Male
  • Polyesters (chemistry)
  • Prosthesis Design
  • Quality of Life
  • Stem Cell Transplantation (adverse effects, methods)
  • Time Factors
  • Tissue Engineering (methods)
  • Tissue Scaffolds
  • Treatment Outcome
  • Vascular Patency
  • Vena Cava, Inferior (diagnostic imaging, physiopathology, surgery)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: